Cointime

LiVeritas Biosciences

company

About

Committed to Truth-telling for Early Success in Drug Development

  • 1 - 10

Highlights

Total Funding Amount
$50K
Funding Rounds
2
Investors
2

Details

Last Funding Type
Pre-seed
Last Funding Money Raised
$50K
Industries
Biopharma,Biotechnology
Founded date
Feb 20, 2020
Number Of Employee
1 - 10
Operating Status
Active

LiVeritas Biosciences is a hybrid life science data and analytics company solving the problem of mass spectrometry implementation in the world of drug development. We utilize transformative solutions that unify drug development knowledge, data, insights, and strategy. As a result, we are empowering our clients to harness the power of molecular integrity for early informed decision-making helping them advance the right candidates early in drug development.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$50K
LiVeritas Biosciences has raised a total of $50K in funding over 2 rounds. Their latest funding was raised on Feb 1, 2021 from a Non-Equity Assistant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 1, 2021 Non-Equity Assistant — 1 — — Detail
May 27, 2020 Pre-seed $50K 1 EXPERT DOJO — Detail

Investors

Number of Lead Investors
Number of Investors
1
2
LiVeritas Biosciences is funded by 2 investors. EXPERT DOJO and Newchip are the most recent investors.
Investor Name Lead Investor Funding Round
EXPERT DOJO Yes Pre-seed
Newchip — Non-Equity Assistant
Cointime
Содержание
компания